92 related articles for article (PubMed ID: 8532401)
1. [Proliferative activity of ependymomas. (Quantitative analysis of the expression of Ki67 and AgNOR)].
Ferraraccio F; Accardo M; Cuccurullo L
Pathologica; 1995 Apr; 87(2):112-20. PubMed ID: 8532401
[TBL] [Abstract][Full Text] [Related]
2. [Significance of the AgNOR in tumor pathology].
Pich A; Margaria E; Chiusa L
Pathologica; 2002 Feb; 94(1):2-9. PubMed ID: 11912874
[TBL] [Abstract][Full Text] [Related]
3. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
Suri VS; Tatke M; Singh D; Sharma A
Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
[TBL] [Abstract][Full Text] [Related]
4. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool.
Giuffrè G; Mormandi F; Barresi V; Bordi C; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(1):45-50. PubMed ID: 16584984
[TBL] [Abstract][Full Text] [Related]
5. Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker.
Preusser M; Heinzl H; Gelpi E; Höftberger R; Fischer I; Pipp I; Milenkovic I; Wöhrer A; Popovici F; Wolfsberger S; Hainfellner JA
Histopathology; 2008 Jul; 53(1):39-47. PubMed ID: 18613924
[TBL] [Abstract][Full Text] [Related]
6. [The proliferative activity in epithelial hyperplasia of the breast].
Kaneko M; Arihiro K; Fujii S; Inai K
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():46-51. PubMed ID: 7747992
[TBL] [Abstract][Full Text] [Related]
7. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
8. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
Singh M; Prasad S; Kalra N; Singh U; Shukla Y
Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
[TBL] [Abstract][Full Text] [Related]
9. The study of AgNOR proteins in leukemias: diagnostic value and correlation to S-phase cell fraction.
Klobusická M; Babusíková O; Mesárosová A; Kusenda J; Glasová M
Neoplasma; 1996; 43(6):397-401. PubMed ID: 8996564
[TBL] [Abstract][Full Text] [Related]
10. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between the grade of histological malignancy and nuclear positivity using the AgNOR technique in 6 cases of isolated bone NHL].
Cosimi MF; Casagranda I; Porta C; Moroni M; Orsi R; Nastasi G
Sangre (Barc); 1992 Oct; 37(5):399-402. PubMed ID: 1293782
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of AgNOR and Ki-67 antigen as cell kinetic parameters in oral dysplasias and carcinomas.
Zoeller J; Flentje M; Sinn P; Born IA
Anal Cell Pathol; 1994 Jul; 7(1):77-88. PubMed ID: 7981138
[TBL] [Abstract][Full Text] [Related]
14. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
[TBL] [Abstract][Full Text] [Related]
15. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
16. [The significance of the nucleolus organizer region antigen for the differentiation of laryngeal dysplasias and laryngeal carcinoma].
Martin H; Greiner K; Beil M; Hufnagl P
HNO; 1996 Jan; 44(1):22-6. PubMed ID: 8819725
[TBL] [Abstract][Full Text] [Related]
17. [AgNOR analysis of astrocytoma in childhood].
Haberland C; Martin H; Guski H; Hufnagl P; Vogel S
Zentralbl Neurochir; 1996; 57(1):5-11. PubMed ID: 8900893
[TBL] [Abstract][Full Text] [Related]
18. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
Derenzini M; Trerè D
Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of three-dimensional distribution of AgNOR proteins during interphase in leukemic cells.
Wozniak ZM; Usson Y; Parazza F; Champelovier P; Leroux D; Seigneurin D
Cytometry; 1996 May; 24(1):14-26. PubMed ID: 8723898
[TBL] [Abstract][Full Text] [Related]
20. AgNOR and breast cancer. A study by image analysis.
Ronco A; Larran J; López A; Vilches J
Histol Histopathol; 1994 Apr; 9(2):309-13. PubMed ID: 8075491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]